Early-life nutrition is increasingly recognized as a critical determinant of health trajectories extending far beyond infancy and childhood. Recent research underscores the profound influence of nutritional exposures during the perinatal period on susceptibility to both communicable and non-communicable diseases across the lifespan. This review synthesizes the latest evidence from epidemiological, mechanistic, and clinical studies, highlighting the implications of early nutritional status on the developmental origins of health and disease (DOHaD). It discusses epidemiology, pathophysiology, risk factors, clinical features, diagnostic considerations, management strategies, recent advances, and guideline-based recommendations, providing a comprehensive resource for healthcare professionals.
The notion that early nutritional exposures imprint lifelong health outcomes forms the cornerstone of the Developmental Origins of Health and Disease (DOHaD) hypothesis. Nutritional status during gestation, infancy, and early childhood modulates the risk of metabolic, cardiovascular, immunologic, and neurodevelopmental disorders. Mounting evidence from large cohort studies, randomized controlled trials, and mechanistic research emphasizes the importance of optimizing maternal and infant nutrition to mitigate the global burden of disease. This article reviews the multifaceted impact of early-life nutrition and translates current evidence into practical clinical insights.
Globally, suboptimal early-life nutrition remains a significant contributor to morbidity and mortality. According to the World Health Organization (WHO), over 149 million children under five are stunted, and 45 million are wasted, with undernutrition accounting for nearly 45% of deaths in this age group. Conversely, childhood overweight and obesity are rising globally, affecting over 38 million children under five. Both extremes of the nutritional spectrum are associated with increased risk of non-communicable diseases (NCDs), including type 2 diabetes, hypertension, coronary artery disease, and neurodevelopmental disorders, thus perpetuating intergenerational cycles of ill health.
The pathophysiological mechanisms underlying the long-term effects of early-life nutrition are complex, involving epigenetic modulation, hormonal programming, and alterations in organ development. Suboptimal maternal nutrition can trigger adaptive responses in the fetus, such as altered placental function and changes in gene expression (e.g., DNA methylation), predisposing to insulin resistance, dyslipidemia, and altered appetite regulation in later life. Inadequate intake of critical micronutrients (e.g., iron, iodine, folate) disrupts neurogenesis and immune maturation, increasing susceptibility to infections and neurodevelopmental impairment. Conversely, excessive caloric intake or gestational diabetes may induce fetal hyperinsulinemia, increasing adiposity and metabolic risk.
Key risk factors for adverse nutritional programming include maternal undernutrition, obesity, micronutrient deficiencies, short interpregnancy intervals, and exposure to environmental toxins. Socioeconomic deprivation, food insecurity, and limited access to healthcare exacerbate these risks. Genetic predispositions may interact with environmental exposures, further modulating disease risk. Preterm birth and low birth weight amplify vulnerability to postnatal nutritional deficits, heightening the risk of stunting, developmental delay, and cardiometabolic disease in adulthood.
Early-life nutritional deficiencies manifest clinically as intrauterine growth restriction, low birth weight, failure to thrive, and micronutrient deficiency syndromes. Overnutrition may present as macrosomia, rapid postnatal weight gain, and early onset obesity. Long-term, individuals may exhibit impaired cognitive development, behavioral disorders, and increased incidence of metabolic syndrome, hypertension, and type 2 diabetes. The clinical spectrum is influenced by the timing, duration, and severity of nutritional insults, with critical windows of vulnerability during gestation and the first two years of life.
Diagnosis of early-life nutritional disorders involves comprehensive antenatal and postnatal assessment, including maternal dietary history, anthropometry, biochemical markers (e.g., hemoglobin, serum ferritin, vitamin D, iodine status), and growth monitoring in infants. Advanced imaging (e.g., ultrasound for fetal biometry) and neurodevelopmental screening may be warranted. Genomic and epigenomic profiling are emerging as tools for risk stratification and personalized intervention, though their clinical utility remains investigational.
Optimal management hinges on a life-course approach, starting with preconception and antenatal care to ensure maternal nutritional adequacy. Interventions include balanced energy-protein supplementation, targeted micronutrient supplementation (e.g., iron, folic acid, iodine), and promotion of exclusive breastfeeding for the first six months. Responsive complementary feeding, timely introduction of diverse foods, and avoidance of ultra-processed foods are central to postnatal nutrition. Multidisciplinary care, including dietitians, primary care, and public health teams, is essential for at-risk populations. Early identification and management of feeding difficulties, growth faltering, or obesity are critical to optimize outcomes.
Emerging research highlights the potential of precision nutrition, leveraging genetic, metabolic, and microbiome data to tailor interventions. Probiotic and prebiotic supplementation during pregnancy and infancy are under investigation for their roles in immune and metabolic programming. Fortification strategies and biofortified crops address micronutrient deficiencies at the population level. Digital health tools and mobile applications facilitate dietary tracking and remote monitoring, improving adherence and scalability of interventions. Ongoing clinical trials are evaluating novel approaches such as maternal omega-3 fatty acid supplementation and in utero nutrient delivery systems.
Major organizations, including the WHO, UNICEF, and national pediatric societies, advocate for comprehensive maternal and infant nutrition strategies. Key recommendations include antenatal iron and folic acid supplementation, universal salt iodization, promotion of exclusive breastfeeding, and age-appropriate complementary feeding. Guidelines emphasize the importance of monitoring growth trajectories, early detection of under- or overnutrition, and integrated management of comorbidities. Public health policies should prioritize food security, maternal education, and access to healthcare services to address social determinants of nutritional risk.
Early-life nutrition exerts a profound and enduring influence on lifelong health, shaping susceptibility to a spectrum of diseases through complex biological mechanisms. Clinicians play a pivotal role in promoting optimal maternal and child nutrition, early detection of risk factors, and evidence-based interventions. Advances in precision nutrition and public health strategies hold promise for mitigating the global burden of nutrition-related disorders. Continued research and policy innovation are essential to translate scientific insights into sustainable improvements in population health.
1.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Hereditary cancer has a rare and underreported cause.
4.
New imaging guidelines for head and neck cancers, a step toward practice change
5.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
1.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Essential Updates in Hematology in Daily Practice
4.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
5.
Importance of Early Detection in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation